Get startedLog in
    Picture of ISR Immune System Regulation Holding AB (publ) logo

    ISR — ISR Immune System Regulation Holding AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro Cap
    All News

    Brief: ISR Initiates Collaboration With Chinese InnoStar For The Treatment Of Hepatitis B

    Picture of ISR Immune System Regulation Holding AB (publ) logoISR Immune System Regulation Holding AB (publ)
    15/01/2020 07:03
    Jan 15 (Reuters) - ISR Immune System Regulation Holding AB
 ISR.ST :
    * CO'S BOARD OF DIRECTORS DECIDED ON TUESDAY TO INITIATE
STRATEGIC
COLLABORATION WITH RENOWNED CHINESE CRO COMPANY SHANGHAI
INNOSTAR BIOTECH
    * THE GOAL OF THE COLLABORATION IS TO DEVELOP ISR'S DRUG
CANDIDATE
ISR050 FOR TREATMENT OF HEPATITIS B
    * CO'S DRUG CANDIDATE IS NOW IN FINAL STAGE OF THE
PRECLINICAL
PHASE

    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr7gXp5f
    
 Further company coverage:  ISR.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))

    Recent news on ISR Immune System Regulation Holding AB (publ)

    See all news